Cancer Surveys: Advances and Prospects in Clinical, Epidemiological and Laboratory Oncology, vol 1 No. 1 1982

Por Ponder, B A J
Publicado em 1983

Complete heart block in patients with peroneal muscular atrophy

Por Ponder, B. A. J., Chatterjee, K., Sutton, G. C.
Publicado em 1971

A Taqi polymorphism in the human NF1 gene

Por Xu, W., Liu, L., Ponder, M., Ponder, B.A.J.
Publicado em 1991

A BgIII polymorphism in the human NF1 gene

Por Xu, W., Liu, L., Black, D.M., Ponder, B.A.J.
Publicado em 1991

A new polymorphism in the ret protooncogene (RET)

Por Mulligan, L.M., Gardner, E., Papi, L., Ponder, B.A.J.
Publicado em 1991

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer

Por Unoki, M, Kelly, J D, Neal, D E, Ponder, B A J, Nakamura, Y, Hamamoto, R
Publicado em 2009

Common germ-line polymorphism of C1QA and breast cancer survival

Por Azzato, E M, Lee, A J X, Teschendorff, A, Ponder, B A J, Pharoah, P, Caldas, C, Maia, A T
Publicado em 2010

Interactions between genes involved in the antioxidant defence system and breast cancer risk

Por Oestergaard, M Z, Tyrer, J, Cebrian, A, Shah, M, Dunning, A M, Ponder, B A J, Easton, D F, Pharoah, P D P
Publicado em 2006

Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours

Por Özdağ, H, Batley, S J, Försti, A, Iyer, N G, Daigo, Y, Boutell, J, Arends, M J, Ponder, B A J, Kouzarides, T, Caldas, C
Publicado em 2002

Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population

Por Lesueur, F, Song, H, Ahmed, S, Luccarini, C, Jordan, C, Luben, R, Easton, D F, Dunning, A M, Pharoah, P D, Ponder, B A J
Publicado em 2006

Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese

Por Hu, S P, Day, N E, Li, D R, Luben, R N, Cai, K L, Ou-Yang, T, Li, B, Lu, X Z, Ponder, B A J
Publicado em 2005

Mutation testing in melanoma families: INK4A, CDK4 and INK4D

Por Newton Bishop, J A, Harland, M, Bennett, D C, Bataille, V, Goldstein, A M, Tucker, M A, Ponder, B A J, Cuzick, J, Selby, P, Bishop, D T
Publicado em 1999

HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer

Por Benusiglio, P R, Pharoah, P D, Smith, P L, Lesueur, F, Conroy, D, Luben, R N, Dew, G, Jordan, C, Dunning, A, Easton, D F, Ponder, B A J
Publicado em 2006

Linkage analysis of chromosome 17 markers in British and South African families with neurofibromatosis type 1

Por Mathew, C. G. P., Thorpe, K., Easton, D. F., Chin, K. S., Jadayel, D., Ponder, M., Moore, G., Wallis, C. E., Slater, C. P., De Jong, G., O'Connell, P., White, R., Barker, D., Ponder, B. A. J.
Publicado em 1989

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

Por Whittemore, A S, Balise, R R, Pharoah, P D P, DiCioccio, R A, Oakley-Girvan, I, Ramus, S J, Daly, M, Usinowicz, M B, Garlinghouse-Jones, K, Ponder, B A J, Buys, S, Senie, R, Andrulis, I, John, E, Hopper, J L, Piver, M S
Publicado em 2004

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer

Por Quaye, L, Song, H, Ramus, S J, Gentry-Maharaj, A, Høgdall, E, DiCioccio, R A, McGuire, V, Wu, A H, Van Den Berg, D J, Pike, M C, Wozniak, E, Doherty, J A, Rossing, M A, Ness, R B, Moysich, K B, Høgdall, C, Blaakaer, J, Easton, D F, Ponder, B A J, Jacobs, I J, Menon, U, Whittemore, A S, Krüger-Kjaer, S, Pearce, C L, Pharoah, P D P, Gayther, S A
Publicado em 2009